School of Medicine
Showing 1,051-1,100 of 1,201 Results
-
Allison L. Thompson, Ph.D.
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Allison Thompson specializes in the treatment of Post-Traumatic Stress Disorder, anxiety and depression, and severe mental illness. She has practiced at Stanford since 2008. She has a special interest in the treatment of underrepresented and underserved populations, such as people of color.
-
Dolores Gallagher Thompson, PhD, ABPP
Professor (Research) of Psychiatry and Behavioral Science (Public Mental Health and Population Sciences), Emerita
Current Research and Scholarly InterestsMy current research focuses on use of technology to improve mental health of older persons and their family members. I have a strong interest in how cultural diversity impacts mental health access, services, and outcomes. I am currently involved in several international research and demonstration projects in collaboration with the World Health Organization and the health care system in Thailand as well as projects in the US - notably, with rural caregivers and those of Asian American ancestry.
-
Jamie L. Tingey, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Research and Scholarly InterestsDr. Tingey’s research broadly focuses on factors that promote positive outcomes in patients with complex and/or chronic conditions. She is committed to research that focuses on outcomes that are valued by patients and healthcare stakeholders.
Some of her research interests include self-management interventions in chronic conditions (e.g., multiple sclerosis, stroke, spinal cord injury, traumatic brain injury) and adapting evidence-based treatments to provide equitable care to individuals with chronic conditions and disabilities. She is also passionate about integrating psychology services into critical care settings to improve health outcomes among ICU survivors. -
Julie Tinklenberg
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Vaden Health Center
BioDr. Julie Tinklenberg specializes in the treatment of mental illness in the university setting. She has worked in college mental health for over 15 years. Dr.Tinklenberg has a special interest in anxiety disorders, parenting issues, mood disorders and interpersonal/relationship problems.
-
Hui Qi Tong
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioClinical Professor, Stanford Department of Psychiatry & Behavioral Sciences
Clinical Associate Professor, Stanford Department of Psychiatry & Behavioral Sciences
HS Clinical Assistant Professor, UCSF Department of Psychiatry & San Francisco VA Health Care
Staff Psychologist: Women's Mental Health Program, San Francisco VA Health Care System
Academic visitor: Oxford Mindfulness Center, Department of Psychiatry, Oxford University
Psychology Post-doctoral Fellowship: UCSF/San Francisco VA Health Care System
Psychology Pre-doctoral Internship: UCSF/San Francisco VA Health Care System
Psychology Education: Pacific Graduate School of Psychology, Palo Alto University (2008)
Clinical Research Associate: Department of Psychiatry, Tufts University School of Medicine
Research Fellow: Genetics Division, Department of Medicine, Boston Children's Hospital,Harvard Medical School
Medical Education: Fudan University, Shanghai Medical College, Shanghai, China (1994) -
Aubrey Toole, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Aubrey Toole is a licensed psychologist whose research and clinical work has focused on the treatment and prevention of eating and body image problems and the potential benefits of compassion- and acceptance-based interventions. Dr. Toole further specializes in treating eating and body image concerns in high performance athletes at Stanford. Clinically, she works with a range of presentations, including eating and body image concerns, mood and anxiety difficulties, interpersonal problems, and post-traumatic stress, as well as rigid perfectionism, harsh self-critical thinking, and shame. She completed her bachelor’s degree in Psychology with Highest Honors at UC Berkeley and her Ph.D. in Clinical Psychology at Emory University. She completed her predoctoral internship at the Emory University School of Medicine Department of Psychiatry, where she worked with children, adolescents, and young adults with eating disorders, emotion regulation difficulties, anxiety, depression, OCD, and PTSD. She completed her postdoctoral fellowship at Stanford University’s School of Medicine within the Psychosocial Treatment Clinic, where her training focused on evidence-based treatments for eating disorders, anxiety and mood disorders, couples, and high-performance athletes, as well as clinical supervision.
-
Jacob Towery
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioJacob Towery, MD is an adolescent and adult psychiatrist in private practice in Palo Alto, California. He attended Duke University for his undergraduate studies, University of Virginia for medical school, and Stanford for his residency in adult psychiatry and fellowship in adolescent psychiatry. He is the author of "The Anti-Depressant Book," available on Amazon. He currently serves on the Adjunct Faculty at Stanford University School of Medicine. He enjoys seeing patients, snowboarding, scuba diving, traveling, reading fantasy novels, meditating, spending quality time with other humans, making gratuitously long lists, and writing about himself in the third person. More information can be found at www.jacobtowerymd.com
-
Ranak Trivedi
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsEnhancing the role of informal caregivers in chronic disease self-management; assessment and treatment of mental illness in primary care settings; psychosocial antecedents and consequences of cardiovascular disease.
-
Mickey Trockel
Professor of Psychiatry and Behavioral Sciences
BioMickey Trockel is the Director of Evidence Based Innovation for the Stanford University School of Medicine WellMD Center. His development of novel measurement tools has led to growing focus on professional fulfillment as a foundational aim of efforts to promote physician well-being. His scholarship also identifies interpersonal interactions at work as a modifiable core determinate of an organizational culture that cultivates wellness.
Dr. Trockel serves as the chair of the Physician Wellness Academic Consortium Scientific Board, which is a group of academic medical centers working together to improve physician wellbeing. The consortium sites have adopted the physician wellness assessment system Dr. Trockel and his colleagues have developed, which offers longitudinal data for benchmarking and natural experiment based program evaluation. His previous research included focus on college student health, and evaluation of the efficacy of a national evidence based psychotherapy dissemination effort. His more recent scholarship has focused on physician wellbeing. He is particularly interested in developing and demonstrating the efficacy of interventions designed to promote wellbeing by improving social culture determinants of wellbeing across student groups, employee work teams, or larger organizations. -
Themistoklis Tsarouchas
Postdoctoral Scholar, Psychiatry
BioThemis completed his PhD at the Centre for Discovery Brain Sciences of the University of Edinburgh in Scotland under Prof Catherina Becker, with focus on the contribution of the innate immune system during regeneration of the zebrafish spinal cord. As a postdoctoral researcher with Prof Anna Williams at the Centre for Regenerative Medicine in Edinburgh he worked on the molecular mechanisms that regulate the differentiation and functional maturation of human oligodendrocytes. Over the last few years, he worked on several projects focused on the identification of genes that regulate the axonal regeneration of spinal cord after injury and the differentiation of human oligodendrocyte progenitor cells into myelin producing oligodendrocytes. As a member in the Gibson lab, Themis aims to identify molecular regulators of the circadian clock and how tuning the circadian system affects the maturation and function of oligodendrocytes in health and disease.
-
Yuri Tsutsumi
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical Psychology
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone MD, PhD is an Assistant Professor with Stanford School of Medicine’s Department of Psychiatry and Behavioral Sciences. As a neuroscientist, he leads a lab interested in biological mechanisms of mental illness and investigating new therapies for mood disorders and addiction. In particular, he is defining new cell types and evolutionary conserved circuits in emotional processing centers of the brain, with the hope of finding new entry points for novel therapeutics. Working with Dr Robert Malenka, he is using optogenetic, chemogenetic, neuroimaging and behavioral approaches in mouse models of addiction to uncover vulnerable brain circuitry in opioid use disorder. Alongside Dr Alan Schatzberg, he is investigating the efficacy of buprenorphine augmentation to IV ketamine infusion at reducing suicidality in treatment resistant depression.
Clinically, he works collaboratively in the department’s Neuropsychiatry clinic and his clinical focus includes treating patients with diverse and complex presentations at the interface of psychiatry and neurology with particular interest in functional neurological disorders. He sees a small cohort of psychotherapy patients in Individual Psychotherapy Clinic. He also works weekend shifts on Stanford’s inpatient psychiatry units.
Prior to training in psychiatry at Stanford’s research residency track Jason received his bachelor’s degree in biology and philosophy from Union College. He spent three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke investigating and developing MRI reportable contrast agents to map neuronal connectivity. Following this he entered the Medical Scientist Training Program (MD/PhD) at the State University of NY Stony Brook University. There he completed a doctoral dissertation in neuroscience under the mentorship Dr. Josh Huang at Cold Spring Harbor Laboratory. His thesis work employed mouse genetic dissections of excitatory and inhibitory cortical circuits with a focus on the circuitry of chandelier inhibitory interneurons in prefrontal cortex.
In addition to his research and clinical work, Jason is passionate about teaching, mentorship, and resident clinical supervision. He joined a working group early in his clinical residency to restructure trainee’s neuroscience education. He teaches introductory lectures in the neuroscience of addiction, PTSD, psychosis, and mood disorders. He also leads resident group supervision in their introductory psychodynamic psychotherapy clinical experience. He supervises medical students, residents, and clinical fellows in Neuropsychiatry clinic. Finally, committed to the Stanford clinical community, he leads a support group for Internal Medicine interns and residents. -
Laura Turner-Essel, PhD
Program Manager, Psychiatry and Behavioral Sciences
Current Role at StanfordProgram Manager, Department of Psychiatry and Behavioral Sciences
-
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Axel Valle, PsyD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Axel Valle is a licensed clinical psychologist providing individual psychotherapy in English and Spanish. He specializes in cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders, with additional expertise in working with high-performance athletes.
Dr. Valle brings a distinctive international clinical background to his practice. He completed his postdoctoral fellowship at Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences and earned his doctorate in clinical psychology from The Wright Institute in Berkeley. He also holds a Master’s degree in crisis and trauma from Tel Aviv University and is a licensed clinical psychologist in Mexico City, his place of origin. -
Peter Johannes van Roessel
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive ‘awareness’ (insight) in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAt Brainstorm: The Stanford Lab for Mental Health Innovation, we lead the way in digital well-being: translating cutting-edge research into practical solutions for healthier tech use.
We are first and foremost practicing physicians; we treat patients and families. Then, grounded by the foundational oath in medicine to “do no harm,” we help companies build products that prioritize user health with responsibility and care. Our work has shaped platforms used by millions—helping Pinterest design "compassionate search", guiding TikTok in healthy screen-time management, and partnering with ML Commons to establish the first mental health safety benchmarks for large language models (LLMs).
Brainstorm is further committed to “do good” by leveraging these technologies to build a healthier digital world. We advised Dove’s Self-Esteem Project and Real Beauty Prompt Playbook, which studied AI’s impact on beauty and set new digital standards of representation. Additionally, after sharing the results of research conducted with the Stanford Center for AI Safety on the ethics, efficacy, and safety of LLMs providing mental health support, we developed the “Framework for Healthy AI” to guide industry best practices in AI product innovation.
As we apply this expertise to improve users' daily lives, it’s clear that addressing digital intimacy presents unique challenges compared to traditional human relationships. This technology is still emerging, and we are all adapting to it in real-time as it evolves. The big question is: How can we help users cultivate healthy, safe digital relationships?
After seeing success with the Stanford Social Media Safety Plan, which reduced harmful digital behaviors among users, we are now designing the Stanford GenAI Psychological Safety Plan (GPS). The Stanford GPS is a tool to help individuals, tech developers, and policymakers navigate this new terrain and make informed decisions about AI’s role in mental health.
Check out the start of the Stanford GPS in Fortune: This 4-question quiz from Stanford psychiatrists can help protect from the dangers of AI. -
Cristiana Vattuone, PhD
Clinical Research Associate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Vattuone is a clinician and researcher for the Autism and Developmental Disorders Research Program in the Division of Child Psychiatry and Behavioral Sciences. Dr. Vattuone's expertise includes clinical and neuropsychological assessment of autism spectrum disorder and associated genetic conditions. Dr. Vattuone received her Ph.D. in Human Development and Psychology from the University of California, Los Angeles with specialized training in evidence-based interventions. Dr. Vattuone’s research efforts focus on the early identification, diagnosis, and treatment of infants and toddlers, developmental trajectories, and the role of the family in supporting positive outcomes. Her dedication to research, treatment, and training continues at ADDRP to support individuals with autism spectrum disorder and their families.
-
Mytilee Vemuri
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am a Clinical Assistant Professor of Psychiatry, with clinical and research interests in hormonal influences on women’s mental and cognitive health. After Psychiatry residency I completed a NIMH research fellowship studying gender differences in metabolic complications such as dyslipidemia, obesity, and insulin-resistance in patients with bipolar disorder. As a research fellow, I also provided clinical oversight for research participants in studies evaluating hormonal change, metabolic biomarkers and mood. More recently, I have collaborated with PI Duncan and her research group on projects studying relationships between sex hormones and mood/anxiety disorders, particularly in peri-menopausal women. From these experiences I have gained experience in conducting clinical research and collaborating in interdisciplinary research teams. I have also had over 20 years of clinical experience as an attending psychiatrist in Stanford Women’s Wellness psychiatry, general psychiatry and primary care clinics treating a wide range of psychiatric conditions including perimenopausal and geriatric mood disorders. I have published review articles detailing the evidence-basis for treating mood disorders in women during times of hormonal change, and the role of hormones as potential treatments. I also serve as the Stanford Psychiatry Department’s clinical quality improvement leader, where I oversee multiple interdisciplinary improvement teams charged with improving the quality and efficiency of care processes. I currently specialize in managing perimenopausal mood disorders and have an interest in the judicious use of menopausal hormone therapy as an adjunctive treatment for mood symptoms in this population. My clinical and research experience in the intersection of women’s mental health, sex-steroid hormones, and the perimenopause, along with broad experience working on cross-disciplinary teams, will bring valuable input to this research team.
-
Janani Venugopalakrishnan
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsAutism spectrum disorders
-
Daniel Virtheim
Clinical Research Coordinator, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator
-
Allison Vreeland
Clinical Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Allison Vreeland (she/her) is a licensed clinical psychologist specializing in working with children, teens, and families. Dr. Vreeland received her PhD in Clinical Psychological Science with a minor in Quantitative Studies at Vanderbilt University. She completed her predoctoral clinical internship in Child Psychology at UCSF with specialty training through the Child Trauma Research Program. She completed a research and clinical fellowship in the Immune Behavioral Health Clinic at Stanford University, where she focused her research efforts on examining neurological markers of patients diagnosed with pediatric acute neuropsychiatric syndrome (PANS). Clinically, Dr. Vreeland’s program of clinical care is focused on the delivery of evidence-based clinical interventions for individuals with anxiety, OCD, PANS/PANDAS, mood disorders, and behavioral challenges.
